pyrroles has been researched along with Cancer of Skin in 69 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (1.45) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 16 (23.19) | 29.6817 |
| 2010's | 40 (57.97) | 24.3611 |
| 2020's | 12 (17.39) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, MP; Ferraldeschi, R; Ferrari, N; Gewinner, C; Jueliger, S; Keer, H; Lyons, J; Munck, J; Saini, H; Sims, MJ; Smyth, T; Ward, G | 1 |
| Bhol, CS; Bhutia, SK; Mohapatra, S; Panda, S | 1 |
| Blackham, A; Box, J; Demberger, L; Federowicz, B; Friedland, JC; Ginn, S; Horton, M; Knoerzer, D; McIntosh, A; Nair, S; Shapiro, M; Sheikh, H; Stuhlmiller, TJ; Wolfe, Z | 1 |
| Bazinet, A; Bhalla, K; Borthakur, G; Curry, JL; Daver, N; Heberton, M; Kadia, T; Khoury, JD; Kim, K; Konopleva, M; Loghavi, S; Miller, D; Pemmaraju, N; Pierce, S; Wilson, NR | 1 |
| Compérat, EM; Hassler, MR; Rebhan, K; Shariat, SF; Wasinger, G | 1 |
| D'Haens, GR; Guo, X; Kulisek, N; Lawendy, N; Modesto, I; Mundayat, R; Ng, SC; Panaccione, R; Panés, J; Sandborn, WJ; Sands, BE; Su, C; Vranic, I | 1 |
| Bhatt, DL; Chen, YH; Connell, CA; Curtis, JR; Gómez-Reino, JJ; Gunay, LM; Menon, S; Sugiyama, N; Vranic, I; Wang, C; Wu, J; Yamaoka, K | 1 |
| Aplin, AE; Chervoneva, I; Erkes, DA; Field, CO; Rosenbaum, SR; Villanueva, J | 1 |
| Agarwal, P; Krishna, M; Lang, M; Liao, PJ; Linehan, WM; Matsumoto, S; Mitchell, JB; Neckers, L; Railkar, R; Ricketts, CJ; Sourbier, C; Trepel, JB; Wei, D; Wei, MH; Yang, Y | 1 |
| Chan, G; Ciorba, MA; Lawendy, N; Lichtenstein, GR; Nduaka, CI; Panés, J; Pedersen, RD; Quirk, D; Rogler, G; Su, C; Thorpe, AJ | 1 |
| Argyle, DJ; Bavcar, S; Buracco, P; de Fornel, P; de Vos, J; Hirschberger, J; Kessler, M; Murphy, S | 1 |
| Belshaw, S; Bower, J; Clarke, M; Cordes, J; Crighton, D; Croft, DR; Drysdale, MJ; Garnett, MJ; Gill, K; Gray, C; Greenhalgh, DA; Hall, JAM; Konczal, J; Lilla, S; McArthur, D; McConnell, P; McDonald, L; McGarry, L; McKinnon, H; McMenemy, C; Mezna, M; Morrice, NA; Munro, J; Naylor, G; Olson, MF; Rath, N; Schüttelkopf, AW; Sime, M; Unbekandt, M | 1 |
| Hu, WT; Lin, FQ; Xu, AE | 1 |
| Click, B; Regueiro, M | 1 |
| Aplin, AE; Chervoneva, I; Erkes, DA; Nikbakht, N; Tiago, M | 1 |
| De Silva, T; Le Marshall, K; Rischin, A | 1 |
| Cuozzo, P; Fattorusso, C; Fiore, D; Forte, G; Franceschelli, S; Gazzerro, P; Pascale, M; Proto, MC; Ramunno, A | 1 |
| Charles, JB; Ehrhart, EJ; Thamm, DH; Weishaar, KM | 1 |
| Breaker, K; Flaig, IP; Flaig, TW; La Rosa, FG; Naam, M | 1 |
| Abe, R; Aoyagi, S; Fujita, Y; Hata, H; Hoshina, D; Saito, N; Shimizu, H; Yoshioka, N | 1 |
| Kaneda, Y; Katayama, I; Masuzawa, M; Nakamura, M; Nishizawa, A; Saeki, K; Satoh, T; Takehara, Y; Yokozeki, H | 1 |
| Busch, C; de Wijn, R; Geisler, J; Kristensen, V; Lønning, PE; Ree, AH; Risberg, K; Røe, K; Tahiri, A | 1 |
| Sato, T; Valsecchi, ME | 1 |
| Behrendt, FF; Gray, BD; Kiessling, F; Lederle, W; Mottaghy, FM; Pak, KY; Palmowski, K; Palmowski, M; Rix, A | 1 |
| Gaustad, JV; Hompland, T; Pozdniakova, V; Rofstad, EK; Simonsen, TG | 1 |
| Dell'Aquila, E; Frezza, AM; Grasso, RF; Guida, FM; Lanzetta, G; Santini, D; Silletta, M; Silvestris, N; Tonini, G; Venditti, O; Vincenzi, B | 1 |
| Al Rawashdeh, W; Arns, S; Ehling, J; Gremse, F; Kiessling, F; Knüchel-Clarke, R; Kray, S; Lederle, W; Spöler, F | 1 |
| Chou, A; Field, M; Gill, AJ; Hasovits, C; Hugh, TJ; Paik, J; Pavlakis, N; Toon, CW | 1 |
| Adamus, G; Amundson, D; Boon, CJ; Haanen, JB; Jager, MJ; Kapiteijn, EH; Keunen, JE; Luyten, GP; Marinkovic, M; van Dijk, EH; van Herpen, CM | 1 |
| Bonefeld, CM; Fredholm, S; Geisler, C; Gniadecki, R; Iversen, L; Jønson, L; Kopp, KL; Krejsgaard, T; Lindahl, LM; Litvinov, IV; Mongan, NP; Nastasi, C; Odum, N; Petersen, DL; Sasseville, D; Sibbesen, NA; Wasik, MA; Willerslev-Olsen, A; Woetmann, A | 1 |
| Buchbinder, EI; Giobbie-Hurder, A; Hodi, FS; Lawrence, DP; Linette, GP; McDermott, DF; Ramaiya, NH; Sosman, JA; Van den Abbeele, AD | 1 |
| Anckaert, E; Baurain, JF; De Brakeleer, S; De Grève, J; De Mey, J; Decoster, L; Majois, F; Neyns, B; Rorive, A; Rottey, S; Vande Broek, I | 1 |
| Chen, CY; Chou, YW; Hu, WP; Kuo, KK; Lee, JH; Lin, YT; Senadi, GC; Wang, JJ; Wang, YC | 1 |
| Anzini, M; Biava, M; Brindisi, M; Brogi, S; Cappelli, A; Di Capua, A; Di Cesare Mannelli, L; Ghelardini, C; Giordani, A; Giorgi, G; Pace, S; Poce, G; Rossi, A; Sautebin, L; Sticozzi, C; Valacchi, G | 1 |
| Blackwood, L; Harper, A | 1 |
| Cohen, SB; Sivaraman, P | 1 |
| Ashida, A; Kido, K; Murata, H; Saida, T; Takata, M | 1 |
| Bollée, G; Bruneval, P; Cazajous, G; Fakhouri, F; Goujon, JM; Knebelmann, B; Noël, LH; Patey, N; Robert, C | 1 |
| Froehner, M; Novotny, V; Platzek, I; Wirth, MP; Zastrow, S | 1 |
| Battistella, M; Boukoucha, M; Chami, L; Cribier, B; Duvillard, P; Lassau, N; Mateus, C; Robert, C | 1 |
| Huelsmeyer, MK; Kurzman, ID; Mitzey, AM; Qurollo, B; Rose, BJ; Thamm, DH | 1 |
| Gandhi, M; Guitart, JG; Kuzel, TM; Lacouture, M; Liu, SW | 1 |
| Ardinghi, C; Bani, MR; Bernasconi, S; Carraro, F; Ghilardi, C; Giavazzi, R; Naldini, A; Oliva, P; Silini, A | 1 |
| Kupfer, J | 1 |
| Dykema, K; Ellis, L; Furge, K; Hammers, HJ; Jaspers, J; Netto, G; Paesante, S; Pili, R; Rudek, M; Salumbides, B; Shah, P; Sharma, R; Shen, L; Teh, BT; Verheul, HM | 1 |
| Al-Sarraf, R; Johnson, CS; Malone, EK; Rassnick, KM; Ruslander, DM; Russell, DS; Trump, DL; Wakshlag, JJ | 1 |
| Cagli, B; Intagliata, S; Onetti Muda, A; Perrone, G; Persichetti, P; Santini, D; Segreto, F; Tonini, G | 1 |
| Baryshnikov, A; Grigorieva, I; Lichinitser, M; Solomko, E; Stepanova, E; Vartanian, A | 1 |
| El-Gamal, MI; Jung, MH; Lee, WS; Oh, CH; Sim, T; Yoo, KH | 1 |
| Bunting, L; Kurzman, I; London, C; McCartan, L; Robat, C; Selting, K; Stingle, N; Vail, DM | 1 |
| Alvarez, F; Beaver, L; Bryan, J; Carreras, J; Clifford, C; Ettinger, S; Fulton, L; Gauthier, M; Gill, V; Gillings, S; Haney, S; Henry, C; Hershey, B; Higginbotham, ML; Hillman, L; Jones, P; Kiselow, M; Klein, MK; Krick, E; Ladue, T; London, C; Mathie, T; McNeill, C; Novasad, A; Phillips, B; Stingle, N; Thamm, D; Vail, DM; Vaughan, A; Vickery, K | 1 |
| Andalib, S; Asadpoor, M; Doustar, Y; Garjani, A; Garjani, M; Khorrami, A; Maleki-Dizaji, N; Rezazadeh, H; Soraya, H; Ziaee, M | 1 |
| Bagot, M; Basset-Seguin, N; Battistella, M; Bouaziz, JD; Comte, C; Farges, C; Kerob, D; le Maignan, C; Lebbé, C; Madjessli, N; Pagès, C; Penot, P; Vilmer, C | 1 |
| Cucinotta, M; Oteri, R; Teti, D; Venza, I; Venza, M; Visalli, M | 1 |
| Chao, TC; Chen, PC; Hsiao, FC; Lu, HJ; Ma, H; Shiau, CY; Tzeng, CH; Yen, CC | 1 |
| Carranza, DC; Chen, IY; Collisson, EA; Kolodney, MS | 1 |
| Baselga, J; Cavalli, F; Conte, PF; Deplanque, G; Harris, AL; Hoekman, K; Huisman, H; Kuenen, BC; Madhusudan, S; Pfanner, E; Scigalla, P; Seeber, S; Tabernero, J | 1 |
| Evan, GI; Fox, SB; Harris, AL; Knies-Bamforth, UE; Poulsom, R | 1 |
| Bayle, P; Bazex, J; Chouini-Lalanne, N; D'Incan, M; Drugeon, C; Gadroy, A; Journe, F; Marguery, MC | 1 |
| Dellavalle, RP; Drake, AL; Freeman, SR; Graber, M; Heilig, LF; McNealy, K; Schilling, LM | 1 |
| Bernd, C; Miles, S; Noy, A; Politsmakher, A; von Roenn, J | 1 |
| Balzi, D; Barbera, C; Chirlaque, MD; Fabbrocini, G; Greinert, R; Lauria, C; Loria, D; Mercier, M; Miranda, A; Nieto, A; Rosso, S; Sánchez, MJ; Sancho-Garnier, H; Zanetti, R; Zoccola, M; Østerlind, A | 1 |
| Nishida, T | 1 |
| Ranki, A | 1 |
| Hirth, KP; Menger, MD; Schilling, L; Schmiedek, P; Thurnher, A; Ullrich, A; Vajkoczy, P | 1 |
| Arastéh, K; Hannah, A | 1 |
| Eisenreichová, E; Haladová, M; Józová, B; Mucaji, P; Novotný, L; Vachálková, A | 1 |
| Cabral, JR; Mattocks, AR | 1 |
8 review(s) available for pyrroles and Cancer of Skin
| Article | Year |
|---|---|
Basal cell carcinoma of the prostate: a case report responding to the FGFR inhibitor pemigatinib and literature review.
Topics: Carcinoma, Basal Cell; Humans; Lymph Node Excision; Male; Middle Aged; Morpholines; Prostate; Prostatectomy; Prostatic Neoplasms; Pyrimidines; Pyrroles; Skin Neoplasms | 2022 |
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosphate; Adsorption; Adult; Africa, Eastern; Aged; Air Pollutants; Air Pollution; Air Pollution, Indoor; Alcohol Drinking; Allergens; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Anti-Bacterial Agents; Antibodies; Antibodies, Immobilized; Antigen Presentation; Antigens, CD; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Aptamers, Nucleotide; Asthma; Asthma, Exercise-Induced; Atrophy; Autophagy; Azoospermia; Bacillus cereus; Bacterial Infections; Beclin-1; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biofouling; Biological Monitoring; Biomarkers; Biomarkers, Tumor; Biosensing Techniques; Blastocyst; Bone Neoplasms; Bone Regeneration; Bronchoconstriction; Burkitt Lymphoma; C9orf72 Protein; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Carcinoma, Squamous Cell; Cardiomyopathies; Caregivers; Carmine; Case-Control Studies; Catalysis; Cattle; Cause of Death; CCAAT-Enhancer-Binding Protein-alpha; CD8-Positive T-Lymphocytes; Cefepime; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Cell Transdifferentiation; Chelating Agents; Chemical and Drug Induced Liver Injury, Chronic; Chemoradiotherapy, Adjuvant; Child; Child, Preschool; China; Chlorquinaldol; Cholangiocarcinoma; Cholera; Chromatin; Clinical Trials as Topic; Cognitive Dysfunction; Cohort Studies; Colonic Neoplasms; Colorectal Neoplasms; Colorimetry; Cooking; Coordination Complexes; COVID-19; Creatinine; CRISPR-Cas Systems; Critical Care; Critical Illness; Cross-Sectional Studies; Cryopreservation; Cryoprotective Agents; Cysteine; Cytokines; Device Removal; Diet; Diet, High-Fat; Diet, Mediterranean; Dietary Supplements; Dimethyl Sulfoxide; Dipeptides; Disease Models, Animal; Dithiothreitol; DNA; DNA Repeat Expansion; DNA, Bacterial; DNA, Complementary; Dopamine; Electrochemical Techniques; Electrodes; Endocannabinoids; Environmental Exposure; Environmental Monitoring; Environmental Pollutants; Enzyme-Linked Immunosorbent Assay; Erlotinib Hydrochloride; Escherichia coli; Escherichia coli O157; Esophageal Neoplasms; Esophagitis, Peptic; Ethylene Glycol; Europium; Exanthema; Fallopian Tubes; Feces; Female; Fertilization in Vitro; Fluoresceins; Fluorescent Dyes; Follicle Stimulating Hormone; Follow-Up Studies; Food Microbiology; Forced Expiratory Volume; Forkhead Transcription Factors; Frontotemporal Dementia; G-Quadruplexes; Galactose; Gastroenteritis; Gastrointestinal Diseases; Gastrointestinal Microbiome; Gastrointestinal Neoplasms; Gastrointestinal Tract; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genital Neoplasms, Female; Genome-Wide Association Study; Genome, Viral; Genomics; Genotype; Glucose; Glutathione; Glycerol; Gold; Graphite; GTPase-Activating Proteins; Heat-Shock Proteins; Heme Oxygenase-1; Hepacivirus; Hepatitis C; Hepatocytes; Histamine; Histocompatibility Antigens Class II; Hoarseness; Hospice and Palliative Care Nursing; Humans; Hydrogen; Hydrogen Peroxide; Hydrogen Sulfide; Hydroxybenzoates; Hydroxyl Radical; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperthermia, Induced; Hysteroscopy; Immunoassay; Indigo Carmine; Inflammation; Inflammatory Bowel Diseases; Insulin Resistance; Intensive Care Units; Interleukin-11; Interleukin-6; Interleukins; Iodine Radioisotopes; Iran; Iridium; Islets of Langerhans; Kinetics; Lactation; Lactobacillus; Lactobacillus plantarum; Lamins; Latin America; Lead; Lectins; Leukopenia; Ligands; Limit of Detection; Lipopolysaccharides; Lipoprotein Lipase; Liver; Liver Cirrhosis; Liver Neoplasms; Lolium; Luminescent Measurements; Luminol; Lung; Luteinizing Hormone; Macrophages; Magnetic Phenomena; Magnetic Resonance Imaging; Male; Malnutrition; Maltose; Manganese Compounds; Maternal Nutritional Physiological Phenomena; Melatonin; Metabolic Engineering; Metal Nanoparticles; Metallocenes; Metaplasia; Methicillin-Resistant Staphylococcus aureus; Methylation; Mevalonic Acid; Mexico; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microbial Sensitivity Tests; Microbiota; MicroRNAs; Milk; Mitomycin; Molecular Diagnostic Techniques; Molecular Docking Simulation; Monte Carlo Method; Moringa oleifera; Multiple Sclerosis; Muscle Strength; Muscle, Skeletal; Nanocomposites; Nanotubes, Carbon; Neoadjuvant Therapy; Neoplasms; Neurodegenerative Diseases; Neurotransmitter Agents; NF-E2-Related Factor 2; Nickel; Nitrogen Dioxide; Non-alcoholic Fatty Liver Disease; Nucleic Acid Amplification Techniques; Nucleic Acid Hybridization; Nucleocapsid Proteins; Nutritional Status; Obesity; Osteogenesis; Osteosarcoma; Oxidation-Reduction; Oxides; Oxygen; Oxyquinoline; Pain; Palliative Care; Pancreatic Neoplasms; Pandemics; Particulate Matter; Peroxidase; Peroxidases; Phagocytosis; Phaseolus; Photothermal Therapy; Point-of-Care Systems; Polyethyleneimine; Polymers; Polymorphism, Single Nucleotide; Polysomnography; Postoperative Complications; Pregnancy; Pregnant Women; Prenatal Exposure Delayed Effects; Prevalence; Printing, Three-Dimensional; Probability; Probiotics; Prognosis; Prophages; Prospective Studies; Proteomics; Proto-Oncogene Proteins; Pseudomonas aeruginosa; Pseudomonas putida; Pulmonary Disease, Chronic Obstructive; Pulmonary Embolism; Pyridines; Pyrroles; Quality of Life; Quinolones; Rabbits; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptors, Histamine; Receptors, Histamine H2; Recombinases; Rectal Neoplasms; Reperfusion Injury; Respiration; Respiratory Function Tests; Respiratory Rate; Respiratory Sounds; Retrospective Studies; rho GTP-Binding Proteins; Risk Assessment; Risk Factors; RNA; RNA, Messenger; RNA, Ribosomal, 16S; Robotic Surgical Procedures; Running; Rural Population; Saccharomyces cerevisiae; Salpingectomy; Sarcopenia; SARS-CoV-2; Seeds; Semen; Sensitivity and Specificity; Sepsis; Shock, Septic; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Skin Neoplasms; Sleep Apnea, Obstructive; Soil; Spain; Spectrum Analysis, Raman; Sperm Retrieval; Spermatozoa; Spirometry; Staphylococcus aureus; STAT3 Transcription Factor; Stereoisomerism; Sterilization, Tubal; Stroke Volume; Sulfadiazine; Sulfites; Superoxide Dismutase; Surface Plasmon Resonance; tau Proteins; Testis; Testosterone; Thioredoxin-Disulfide Reductase; Thyroid Neoplasms; Thyroidectomy; Trans-Activators; Transcription Factor AP-1; Treatment Outcome; Triazoles; Triclosan; Trifluridine; Tumor Microenvironment; Tumor Necrosis Factor-alpha; United States; Uracil; Vagina; Vegetables; Ventricular Function, Left; Ventricular Pressure; Vibrio cholerae; Vietnam; Virulence; Vital Capacity; Vitrification; Walking; Water; Water Pollutants, Radioactive; Whole Genome Sequencing; Wind; YAP-Signaling Proteins; Zeolites; Zinc Oxide | 2023 |
Managing Risks with Biologics.
Topics: Antibodies, Monoclonal, Humanized; Biological Products; Demyelinating Diseases; Deprescriptions; Drug Substitution; Gastrointestinal Agents; Humans; Infections; Inflammatory Bowel Diseases; Lymphoma; Melanoma; Neoplasms; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Risk; Risk Assessment; Skin Neoplasms; Tumor Necrosis Factor-alpha; Ustekinumab | 2019 |
Skin cancer associated with the use of sorafenib and sunitinib for renal cell carcinoma.
Topics: Adult; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Female; Humans; Indoles; Kidney Neoplasms; Male; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyrroles; Skin Neoplasms; Sorafenib; Sunitinib | 2013 |
The potential role of sunitinib targeting melanomas.
Topics: Animals; Antineoplastic Agents; Humans; Indoles; Melanoma; Pyrroles; Skin Neoplasms; Sunitinib; Uveal Neoplasms | 2013 |
Malignancy and Janus Kinase Inhibition.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Humans; Incidence; Janus Kinases; Neoplasms; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Skin Neoplasms | 2017 |
Statins, fibrates, and melanoma risk: a systematic review and meta-analysis.
Topics: Atorvastatin; Bezafibrate; Clofibrate; Gemfibrozil; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Incidence; Lovastatin; Melanoma; Odds Ratio; Pravastatin; Pyrroles; Randomized Controlled Trials as Topic; Reproducibility of Results; Simvastatin; Skin Neoplasms; United States | 2006 |
The role of vascular endothelial growth factor (VEGF) in AIDS-related Kaposi's sarcoma.
Topics: AIDS-Related Opportunistic Infections; Angiogenesis Inhibitors; Antiviral Agents; Endothelial Growth Factors; Enzyme Inhibitors; HIV-1; Humans; Indoles; Lymphokines; Neovascularization, Pathologic; Protein Isoforms; Protein-Tyrosine Kinases; Pyrroles; Receptor Protein-Tyrosine Kinases; Receptors, Growth Factor; Receptors, Mitogen; Receptors, Vascular Endothelial Growth Factor; Sarcoma, Kaposi; Skin Neoplasms; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2000 |
10 trial(s) available for pyrroles and Cancer of Skin
| Article | Year |
|---|---|
Tofacitinib for the Treatment of Ulcerative Colitis: An Integrated Summary of up to 7.8 Years of Safety Data from the Global Clinical Programme.
Topics: Colitis, Ulcerative; Herpes Zoster; Humans; Janus Kinase Inhibitors; Opportunistic Infections; Protein Kinase Inhibitors; Pyrroles; Skin Neoplasms; Treatment Outcome | 2023 |
Malignancy risk with tofacitinib versus TNF inhibitors in rheumatoid arthritis: results from the open-label, randomised controlled ORAL Surveillance trial.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Humans; Lung Neoplasms; Pyrroles; Risk Factors; Skin Neoplasms; Treatment Outcome; Tumor Necrosis Factor Inhibitors | 2023 |
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosphate; Adsorption; Adult; Africa, Eastern; Aged; Air Pollutants; Air Pollution; Air Pollution, Indoor; Alcohol Drinking; Allergens; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Anti-Bacterial Agents; Antibodies; Antibodies, Immobilized; Antigen Presentation; Antigens, CD; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Aptamers, Nucleotide; Asthma; Asthma, Exercise-Induced; Atrophy; Autophagy; Azoospermia; Bacillus cereus; Bacterial Infections; Beclin-1; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biofouling; Biological Monitoring; Biomarkers; Biomarkers, Tumor; Biosensing Techniques; Blastocyst; Bone Neoplasms; Bone Regeneration; Bronchoconstriction; Burkitt Lymphoma; C9orf72 Protein; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Carcinoma, Squamous Cell; Cardiomyopathies; Caregivers; Carmine; Case-Control Studies; Catalysis; Cattle; Cause of Death; CCAAT-Enhancer-Binding Protein-alpha; CD8-Positive T-Lymphocytes; Cefepime; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Cell Transdifferentiation; Chelating Agents; Chemical and Drug Induced Liver Injury, Chronic; Chemoradiotherapy, Adjuvant; Child; Child, Preschool; China; Chlorquinaldol; Cholangiocarcinoma; Cholera; Chromatin; Clinical Trials as Topic; Cognitive Dysfunction; Cohort Studies; Colonic Neoplasms; Colorectal Neoplasms; Colorimetry; Cooking; Coordination Complexes; COVID-19; Creatinine; CRISPR-Cas Systems; Critical Care; Critical Illness; Cross-Sectional Studies; Cryopreservation; Cryoprotective Agents; Cysteine; Cytokines; Device Removal; Diet; Diet, High-Fat; Diet, Mediterranean; Dietary Supplements; Dimethyl Sulfoxide; Dipeptides; Disease Models, Animal; Dithiothreitol; DNA; DNA Repeat Expansion; DNA, Bacterial; DNA, Complementary; Dopamine; Electrochemical Techniques; Electrodes; Endocannabinoids; Environmental Exposure; Environmental Monitoring; Environmental Pollutants; Enzyme-Linked Immunosorbent Assay; Erlotinib Hydrochloride; Escherichia coli; Escherichia coli O157; Esophageal Neoplasms; Esophagitis, Peptic; Ethylene Glycol; Europium; Exanthema; Fallopian Tubes; Feces; Female; Fertilization in Vitro; Fluoresceins; Fluorescent Dyes; Follicle Stimulating Hormone; Follow-Up Studies; Food Microbiology; Forced Expiratory Volume; Forkhead Transcription Factors; Frontotemporal Dementia; G-Quadruplexes; Galactose; Gastroenteritis; Gastrointestinal Diseases; Gastrointestinal Microbiome; Gastrointestinal Neoplasms; Gastrointestinal Tract; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genital Neoplasms, Female; Genome-Wide Association Study; Genome, Viral; Genomics; Genotype; Glucose; Glutathione; Glycerol; Gold; Graphite; GTPase-Activating Proteins; Heat-Shock Proteins; Heme Oxygenase-1; Hepacivirus; Hepatitis C; Hepatocytes; Histamine; Histocompatibility Antigens Class II; Hoarseness; Hospice and Palliative Care Nursing; Humans; Hydrogen; Hydrogen Peroxide; Hydrogen Sulfide; Hydroxybenzoates; Hydroxyl Radical; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperthermia, Induced; Hysteroscopy; Immunoassay; Indigo Carmine; Inflammation; Inflammatory Bowel Diseases; Insulin Resistance; Intensive Care Units; Interleukin-11; Interleukin-6; Interleukins; Iodine Radioisotopes; Iran; Iridium; Islets of Langerhans; Kinetics; Lactation; Lactobacillus; Lactobacillus plantarum; Lamins; Latin America; Lead; Lectins; Leukopenia; Ligands; Limit of Detection; Lipopolysaccharides; Lipoprotein Lipase; Liver; Liver Cirrhosis; Liver Neoplasms; Lolium; Luminescent Measurements; Luminol; Lung; Luteinizing Hormone; Macrophages; Magnetic Phenomena; Magnetic Resonance Imaging; Male; Malnutrition; Maltose; Manganese Compounds; Maternal Nutritional Physiological Phenomena; Melatonin; Metabolic Engineering; Metal Nanoparticles; Metallocenes; Metaplasia; Methicillin-Resistant Staphylococcus aureus; Methylation; Mevalonic Acid; Mexico; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microbial Sensitivity Tests; Microbiota; MicroRNAs; Milk; Mitomycin; Molecular Diagnostic Techniques; Molecular Docking Simulation; Monte Carlo Method; Moringa oleifera; Multiple Sclerosis; Muscle Strength; Muscle, Skeletal; Nanocomposites; Nanotubes, Carbon; Neoadjuvant Therapy; Neoplasms; Neurodegenerative Diseases; Neurotransmitter Agents; NF-E2-Related Factor 2; Nickel; Nitrogen Dioxide; Non-alcoholic Fatty Liver Disease; Nucleic Acid Amplification Techniques; Nucleic Acid Hybridization; Nucleocapsid Proteins; Nutritional Status; Obesity; Osteogenesis; Osteosarcoma; Oxidation-Reduction; Oxides; Oxygen; Oxyquinoline; Pain; Palliative Care; Pancreatic Neoplasms; Pandemics; Particulate Matter; Peroxidase; Peroxidases; Phagocytosis; Phaseolus; Photothermal Therapy; Point-of-Care Systems; Polyethyleneimine; Polymers; Polymorphism, Single Nucleotide; Polysomnography; Postoperative Complications; Pregnancy; Pregnant Women; Prenatal Exposure Delayed Effects; Prevalence; Printing, Three-Dimensional; Probability; Probiotics; Prognosis; Prophages; Prospective Studies; Proteomics; Proto-Oncogene Proteins; Pseudomonas aeruginosa; Pseudomonas putida; Pulmonary Disease, Chronic Obstructive; Pulmonary Embolism; Pyridines; Pyrroles; Quality of Life; Quinolones; Rabbits; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptors, Histamine; Receptors, Histamine H2; Recombinases; Rectal Neoplasms; Reperfusion Injury; Respiration; Respiratory Function Tests; Respiratory Rate; Respiratory Sounds; Retrospective Studies; rho GTP-Binding Proteins; Risk Assessment; Risk Factors; RNA; RNA, Messenger; RNA, Ribosomal, 16S; Robotic Surgical Procedures; Running; Rural Population; Saccharomyces cerevisiae; Salpingectomy; Sarcopenia; SARS-CoV-2; Seeds; Semen; Sensitivity and Specificity; Sepsis; Shock, Septic; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Skin Neoplasms; Sleep Apnea, Obstructive; Soil; Spain; Spectrum Analysis, Raman; Sperm Retrieval; Spermatozoa; Spirometry; Staphylococcus aureus; STAT3 Transcription Factor; Stereoisomerism; Sterilization, Tubal; Stroke Volume; Sulfadiazine; Sulfites; Superoxide Dismutase; Surface Plasmon Resonance; tau Proteins; Testis; Testosterone; Thioredoxin-Disulfide Reductase; Thyroid Neoplasms; Thyroidectomy; Trans-Activators; Transcription Factor AP-1; Treatment Outcome; Triazoles; Triclosan; Trifluridine; Tumor Microenvironment; Tumor Necrosis Factor-alpha; United States; Uracil; Vagina; Vegetables; Ventricular Function, Left; Ventricular Pressure; Vibrio cholerae; Vietnam; Virulence; Vital Capacity; Vitrification; Walking; Water; Water Pollutants, Radioactive; Whole Genome Sequencing; Wind; YAP-Signaling Proteins; Zeolites; Zinc Oxide | 2023 |
Phosphorylated KIT as a predictor of outcome in canine mast cell tumours treated with toceranib phosphate or vinblastine.
Topics: Animals; Antineoplastic Agents; Dog Diseases; Dogs; Gene Expression Regulation, Neoplastic; Indoles; Mast-Cell Sarcoma; Phosphorylation; Prospective Studies; Proto-Oncogene Proteins c-kit; Pyrroles; Skin Neoplasms; Vinblastine | 2020 |
Serous Retinopathy Associated with Mitogen-Activated Protein Kinase Kinase Inhibition (Binimetinib) for Metastatic Cutaneous and Uveal Melanoma.
Topics: Adult; Aged; Autoantibodies; Benzimidazoles; Central Serous Chorioretinopathy; Cross-Sectional Studies; Drug Combinations; Electrooculography; Electroretinography; Eye Proteins; Female; Fluorescein Angiography; Humans; Male; Melanoma; Melanoma, Cutaneous Malignant; Middle Aged; Mitogen-Activated Protein Kinase Kinases; Prospective Studies; Protein Kinase C; Pyrroles; Quinazolines; Skin Neoplasms; Subretinal Fluid; Tomography, Optical Coherence; Uveal Neoplasms; Visual Acuity | 2015 |
Phase 2 study of sunitinib in patients with metastatic mucosal or acral melanoma.
Topics: Antineoplastic Agents; Female; Humans; Indoles; Male; Melanoma; Mucous Membrane; Mutation; Proto-Oncogene Proteins c-kit; Pyrroles; Skin Neoplasms; Sunitinib | 2015 |
Biomarker Analysis in a Phase II Study of Sunitinib in Patients with Advanced Melanoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers, Tumor; Endothelial Cells; Endpoint Determination; Female; Humans; Indoles; Male; Melanoma; Middle Aged; Mutation; Neovascularization, Pathologic; Placenta Growth Factor; Pregnancy Proteins; Proto-Oncogene Proteins c-kit; Pyrroles; Skin Neoplasms; Sunitinib; Survival Analysis; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2 | 2015 |
Calcitriol (1,25-dihydroxycholecalciferol) enhances mast cell tumour chemotherapy and receptor tyrosine kinase inhibitor activity in vitro and has single-agent activity against spontaneously occurring canine mast cell tumours.
Topics: Animals; Antineoplastic Agents; Benzamides; Blotting, Western; Calcitriol; Calcium Channel Agonists; Cell Line, Tumor; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Drug Synergism; Female; Imatinib Mesylate; Indoles; Lomustine; Male; Mastocytoma; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Pyrroles; Receptors, Calcitriol; Skin Neoplasms; Treatment Outcome; Vinblastine | 2010 |
Safety evaluation of combination vinblastine and toceranib phosphate (Palladia®) in dogs: a phase I dose-finding study.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Indoles; Male; Mastocytosis; Protein-Tyrosine Kinases; Pyrroles; Skin Neoplasms; Vinblastine | 2012 |
Efficacy and toxicity of the angiogenesis inhibitor SU5416 as a single agent in patients with advanced renal cell carcinoma, melanoma, and soft tissue sarcoma.
Topics: Adult; Aged; Angiogenesis Inhibitors; Carcinoma, Renal Cell; Disease-Free Survival; Enzyme Inhibitors; Female; Humans; Indoles; Kidney Neoplasms; Male; Melanoma; Middle Aged; Neovascularization, Pathologic; Protein-Tyrosine Kinases; Pyrroles; Sarcoma; Skin Neoplasms; Treatment Outcome | 2003 |
52 other study(ies) available for pyrroles and Cancer of Skin
| Article | Year |
|---|---|
Antagonism of inhibitors of apoptosis proteins reveals a novel, immune response-based therapeutic approach for T-cell lymphoma.
Topics: Apoptosis; Humans; Immunity; Lymphoma, T-Cell; Morpholines; Neoplasm Recurrence, Local; Piperazines; Pyrroles; Skin Neoplasms | 2021 |
DSPE-PEG-Coated Uniform Nitrogen-Doped Carbon Capsules for NIR-Mediated Synergistic Chemophototherapy of Skin Cancer.
Topics: Antineoplastic Agents; Capsules; Carbon; Fluorouracil; Humans; Nitrogen; Phosphatidylethanolamines; Pyrroles; Skin Neoplasms | 2021 |
Case report: response to the ERK1/2 inhibitor ulixertinib in BRAF D594G cutaneous melanoma.
Topics: Aminopyridines; Cell Line, Tumor; Humans; MAP Kinase Signaling System; Melanoma; Melanoma, Cutaneous Malignant; Mitogen-Activated Protein Kinase Kinases; Mutation; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Pyrroles; Skin Neoplasms | 2022 |
Major clinical response in a patient with leukemia cutis treated with the bromodomain inhibitor PLX51107 and azacitidine.
Topics: Azacitidine; Humans; Leukemia; Leukemia, Myeloid, Acute; Oxazoles; Pyridines; Pyrroles; Skin Neoplasms | 2022 |
PLX3397 inhibits the accumulation of intra-tumoral macrophages and improves bromodomain and extra-terminal inhibitor efficacy in melanoma.
Topics: Aminopyridines; Animals; Cell Line, Tumor; Cell Proliferation; Macrophages; Male; Melanoma; Mice, Inbred C57BL; Proteins; Proto-Oncogene Proteins B-raf; Pyrroles; Receptors, Granulocyte-Macrophage Colony-Stimulating Factor; Skin Neoplasms; Treatment Outcome | 2020 |
Proteasome inhibition disrupts the metabolism of fumarate hydratase- deficient tumors by downregulating p62 and c-Myc.
Topics: Animals; Carcinoma, Renal Cell; Cell Line, Tumor; Female; Fumarate Hydratase; Gene Expression Regulation, Neoplastic; Germ-Line Mutation; Glutaminase; Glycolysis; Humans; Kidney Neoplasms; Lactate Dehydrogenase 5; Lactones; Leiomyomatosis; Mice; Mice, Nude; Neoplastic Syndromes, Hereditary; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Proto-Oncogene Proteins c-myc; Pyrroles; Sequestosome-1 Protein; Signal Transduction; Skin Neoplasms; Uterine Neoplasms; Xenograft Model Antitumor Assays | 2019 |
Tofacitinib, an Oral Janus Kinase Inhibitor: Analysis of Malignancy (Excluding Nonmelanoma Skin Cancer) Events Across the Ulcerative Colitis Clinical Program.
Topics: Clinical Trials, Phase III as Topic; Colitis, Ulcerative; Humans; Janus Kinase Inhibitors; Neoplasms; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Skin Neoplasms; Treatment Outcome | 2021 |
Combination toceranib and lomustine shows frequent high grade toxicities when used for treatment of non-resectable or recurrent mast cell tumours in dogs: A European multicentre study.
Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Dog Diseases; Dogs; Europe; Indoles; Lomustine; Mast Cells; Neoplasm Recurrence, Local; Prednisolone; Prospective Studies; Pyrroles; Receptor Protein-Tyrosine Kinases; Skin Neoplasms | 2017 |
Discovery of Potent and Selective MRCK Inhibitors with Therapeutic Effect on Skin Cancer.
Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Disease Models, Animal; Drug Discovery; HEK293 Cells; Humans; Mice; Mice, Nude; Myotonin-Protein Kinase; Phosphorylation; Protein Kinase Inhibitors; Pyridines; Pyrimidines; Pyrroles; Skin Neoplasms; Xenograft Model Antitumor Assays | 2018 |
Treatment of halo naevus with the topical Janus kinase inhibitor tofacitinib 1.5.
Topics: Administration, Topical; Back; Child; Dermatologic Agents; Humans; Lip Neoplasms; Male; Nevus, Halo; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Skin Neoplasms | 2018 |
BET Inhibition Modifies Melanoma Infiltrating T Cells and Enhances Response to PD-L1 Blockade.
Topics: Animals; Antineoplastic Agents, Immunological; CD8-Positive T-Lymphocytes; Cell Growth Processes; Cell Line, Tumor; Disease Models, Animal; Drug Synergism; Forkhead Transcription Factors; Humans; Immunotherapy; Lymphocytes, Tumor-Infiltrating; Melanoma; Mice; Nerve Tissue Proteins; Oxazoles; Programmed Cell Death 1 Receptor; Pyridines; Pyrroles; Receptors, Cell Surface; Skin Neoplasms; T-Lymphocytes, Regulatory; Tumor Burden | 2019 |
Reversible eruption of neurofibromatosis associated with tofacitinib therapy for rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Female; Fibroma; Humans; Middle Aged; Neurofibromatosis 1; Piperidines; Pyrimidines; Pyrroles; Skin Neoplasms | 2019 |
Tetra-substituted pyrrole derivatives act as potent activators of p53 in melanoma cells.
Topics: Apoptosis; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p16; HSP90 Heat-Shock Proteins; Humans; Imidazoles; Melanoma; Melanoma, Cutaneous Malignant; Mutation; Piperazines; Proto-Oncogene Proteins c-mdm2; Pyrroles; Skin Neoplasms; Transcription, Genetic; Tumor Suppressor Protein p14ARF; Tumor Suppressor Protein p53 | 2020 |
Establishment of a novel experimental model of human angiosarcoma and a VEGF-targeting therapeutic experiment.
Topics: Aged, 80 and over; Angiogenesis Inhibitors; Animals; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal, Humanized; Bevacizumab; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Hemangiosarcoma; Heterografts; Humans; In Vitro Techniques; Indoles; Male; Mice; Mice, Inbred NOD; Mice, SCID; Pyrroles; Receptor Protein-Tyrosine Kinases; Signal Transduction; Skin Neoplasms; Sunitinib; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2013 |
Anti-tumor effects of inactivated Sendai virus particles with an IL-2 gene on angiosarcoma.
Topics: Animals; Antineoplastic Agents; Bone Marrow Cells; Cell Line, Tumor; Cell Proliferation; Dendritic Cells; Female; Hemangiosarcoma; Indoles; Interferon-gamma; Interleukin-2; Lymphocytes; Mice; Mice, Inbred BALB C; Oncolytic Virotherapy; Protein Kinase Inhibitors; Pyrroles; Sendai virus; Skin Neoplasms; Sunitinib; Tumor Burden; Virion | 2013 |
Differential inhibition of ex-vivo tumor kinase activity by vemurafenib in BRAF(V600E) and BRAF wild-type metastatic malignant melanoma.
Topics: Aged; Cell Line, Tumor; Cluster Analysis; ErbB Receptors; Female; Humans; Indoles; Male; Melanoma; Middle Aged; Mutant Proteins; Mutation; Neoplasm Metastasis; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Pyrroles; Receptor, Platelet-Derived Growth Factor beta; Signal Transduction; Skin; Skin Neoplasms; Substrate Specificity; Sulfonamides; Sunitinib; Vemurafenib | 2013 |
A low molecular weight zinc2+-dipicolylamine-based probe detects apoptosis during tumour treatment better than an annexin V-based probe.
Topics: Amines; Angiogenesis Inhibitors; Animals; Annexin A5; Apoptosis; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Indoles; Mice; Mice, Nude; Molecular Probes; Molecular Weight; Neoplasms, Experimental; Organometallic Compounds; Picolinic Acids; Pyrroles; Skin Neoplasms; Sunitinib; Tumor Cells, Cultured; Zinc | 2014 |
Magnetic resonance imaging identifies early effects of sunitinib treatment in human melanoma xenografts.
Topics: Animals; Antineoplastic Agents; Cell Hypoxia; Female; Humans; Indoles; Magnetic Resonance Imaging; Melanoma, Amelanotic; Mice; Mice, Inbred BALB C; Mice, Nude; Pyrroles; Skin Neoplasms; Sunitinib; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2013 |
Sunitinib in malignant melanoma: a treatment option only for KIT-mutated patients?
Topics: Aged; Biomarkers, Pharmacological; Carcinoma, Renal Cell; Humans; Indoles; Liver Neoplasms; Lung Neoplasms; Male; Melanoma; Mutation; Proto-Oncogene Proteins c-kit; Pyrroles; Skin Neoplasms; Sunitinib | 2013 |
Optical tomography of MMP activity allows a sensitive noninvasive characterization of the invasiveness and angiogenesis of SCC xenografts.
Topics: Angiogenesis Inhibitors; Animals; Biomarkers, Tumor; Carcinoma, Squamous Cell; Female; Humans; Indoles; Matrix Metalloproteinases; Mice, Nude; Neovascularization, Pathologic; Pyrroles; Skin Neoplasms; Stromal Cells; Sunitinib; Tomography, Optical Coherence; Uterine Cervical Neoplasms; X-Ray Microtomography; Xenograft Model Antitumor Assays | 2014 |
Skin rash, a kidney mass and a family mystery dating back to World War II.
Topics: Adult; Alleles; Carcinoma, Renal Cell; Chromosome Deletion; Combined Modality Therapy; Drug Delivery Systems; Exanthema; Fumarate Hydratase; Genetic Counseling; Humans; Indoles; Kidney Medulla; Kidney Neoplasms; Leiomyomatosis; Liver Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Microfluidic Analytical Techniques; Multiplex Polymerase Chain Reaction; Neoplasm Invasiveness; Neoplasm Staging; Neoplasms, Multiple Primary; Nephrectomy; New South Wales; Oligonucleotide Array Sequence Analysis; Precision Medicine; Pyrroles; Rod Opsins; Skin; Skin Neoplasms; Sunitinib; World War II | 2014 |
Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma.
Topics: Cell Line, Tumor; Genes, Tumor Suppressor; Humans; Janus Kinase 3; Lymphoma, T-Cell, Cutaneous; MicroRNAs; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Signal Transduction; Skin Neoplasms; STAT3 Transcription Factor; STAT5 Transcription Factor; Transfection | 2015 |
Design and synthesis of pyrrolobenzodiazepine-gallic hybrid agents as p53-dependent and -independent apoptogenic signaling in melanoma cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzodiazepines; Cell Line, Tumor; Female; Gallic Acid; Humans; Melanoma; Membrane Potential, Mitochondrial; Mice, Inbred ICR; Mitochondria; Models, Molecular; Pyrroles; Reactive Oxygen Species; Signal Transduction; Skin; Skin Neoplasms; Tumor Suppressor Protein p53 | 2016 |
Synthesis and biological evaluation of fluorinated 1,5-diarylpyrrole-3-alkoxyethyl ether derivatives as selective COX-2 inhibitors endowed with anti-inflammatory activity.
Topics: Adult; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Cell Line; Cell Proliferation; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Edema; Halogenation; Humans; Hyperalgesia; Models, Molecular; Pyrroles; Rats; Skin; Skin Neoplasms | 2016 |
Toxicity and response in cats with neoplasia treated with toceranib phosphate.
Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cat Diseases; Cats; Cohort Studies; Female; Indoles; Male; Pyrroles; Retrospective Studies; Skin Neoplasms; Treatment Outcome | 2017 |
Pathological activation of KIT in metastatic tumors of acral and mucosal melanomas.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Female; Humans; Indoles; Male; Melanoma; Middle Aged; Mucous Membrane; Mutation; Neoplasm Metastasis; Phosphorylation; Proto-Oncogene Proteins c-kit; Pyrroles; Skin Neoplasms; Stem Cell Factor; Sunitinib | 2009 |
Thrombotic microangiopathy secondary to VEGF pathway inhibition by sunitinib.
Topics: Adenoma, Sweat Gland; Adult; Antineoplastic Agents; Female; Humans; Indoles; Kidney; Protein Kinase Inhibitors; Pyrroles; Skin Neoplasms; Sunitinib; Thrombosis; Vascular Endothelial Growth Factor A | 2009 |
Treatment of metastatic renal cell cancer with sunitinib during chronic hemodialysis.
Topics: Adult; Antineoplastic Agents; Carcinoma, Renal Cell; Humans; Indoles; Kidney Neoplasms; Lymphatic Metastasis; Male; Pyrroles; Renal Dialysis; Skin Neoplasms; Sunitinib | 2009 |
Sunitinib efficacy in the treatment of metastatic skin adnexal carcinomas: report of two patients with hidradenocarcinoma and trichoblastic carcinoma.
Topics: Acrospiroma; Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Indoles; Male; Middle Aged; Neoplasm Metastasis; Pyrroles; Skin Neoplasms; Sunitinib; Treatment Outcome | 2010 |
RT-PCR-based tyrosine kinase display profiling of canine melanoma: IGF-1 receptor as a potential therapeutic target.
Topics: Animals; Cell Line, Tumor; Dog Diseases; Dogs; Humans; Melanoma; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Pyrroles; Receptor, IGF Type 1; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Skin Neoplasms | 2010 |
Effect of sunitinib on renal cell carcinoma cutaneous metastasis.
Topics: Antineoplastic Agents; Carcinoma, Renal Cell; Humans; Indoles; Kidney Neoplasms; Male; Middle Aged; Pyrroles; Skin Neoplasms; Sunitinib | 2009 |
Protease-activated receptor-1 (PAR-1) promotes the motility of human melanomas and is associated to their metastatic phenotype.
Topics: Animals; Cell Line, Tumor; Cell Movement; Disease Progression; Humans; Melanoma; Mice; Mice, SCID; Neoplasm Metastasis; Pyrroles; Quinazolines; Receptor, PAR-1; Skin Neoplasms | 2010 |
Cutaneous mast cell tumours in dogs.
Topics: Animals; Antineoplastic Agents; Dog Diseases; Dogs; Indoles; Mast-Cell Sarcoma; Pyrroles; Research; Skin Neoplasms | 2010 |
Reversible epithelial to mesenchymal transition and acquired resistance to sunitinib in patients with renal cell carcinoma: evidence from a xenograft study.
Topics: Angiogenesis Inhibitors; Animals; Carcinoma, Renal Cell; Cell Line, Tumor; Disease Progression; Drug Resistance, Neoplasm; Epithelium; Gene Expression Regulation, Neoplastic; Humans; Indoles; Kidney Neoplasms; Mesoderm; Mice; Mice, Nude; Microvessels; Pericytes; Phenotype; Protein Kinase Inhibitors; Pyrroles; Skin Neoplasms; Sunitinib; Von Hippel-Lindau Tumor Suppressor Protein; Xenograft Model Antitumor Assays | 2010 |
Recurrent scrotal hemangiomas during treatment with sunitinib.
Topics: Antineoplastic Agents; Bone Density Conservation Agents; Bone Neoplasms; Carcinoma, Renal Cell; Diphosphonates; Genital Neoplasms, Male; Hemangioma; Humans; Imidazoles; Indoles; Kidney Neoplasms; Male; Middle Aged; Pyrroles; Recurrence; Scrotum; Skin Neoplasms; Sunitinib; Zoledronic Acid | 2010 |
VEGFR1 and PKCα signaling control melanoma vasculogenic mimicry in a VEGFR2 kinase-independent manner.
Topics: Animals; Cell Line, Tumor; Female; Humans; Indoles; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Protein Kinase C-alpha; Pyrroles; RNA, Small Interfering; Signal Transduction; Skin Neoplasms; Transfection; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2 | 2011 |
Design, synthesis, and antiproliferative activity of new 1H-pyrrolo[3,2-c]pyridine derivatives against melanoma cell lines.
Topics: Animals; Antineoplastic Agents; Benzenesulfonates; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Melanoma; Mice; Niacinamide; Phenylurea Compounds; Pyridines; Pyrroles; Skin Neoplasms; Sorafenib; Structure-Activity Relationship | 2011 |
Preliminary evidence for biologic activity of toceranib phosphate (Palladia(®)) in solid tumours.
Topics: Adenocarcinoma; Anal Gland Neoplasms; Anal Sacs; Animals; Antineoplastic Agents; Apocrine Glands; Bone Neoplasms; Carcinoma; Dog Diseases; Dogs; Female; Head and Neck Neoplasms; Indoles; Male; Neoplasms; Nose Neoplasms; Osteosarcoma; Pyrroles; Receptor Protein-Tyrosine Kinases; Skin Neoplasms; Thyroid Neoplasms | 2012 |
Ambivalent effects of atorvastatin on angiogenesis, epidermal cell proliferation and tumorgenesis in animal models.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Atorvastatin; Cell Proliferation; Croton Oil; Epidermal Cells; Epidermis; Female; Heptanoic Acids; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mevalonic Acid; Mice; Neovascularization, Pathologic; Pyrroles; Rats; Rats, Wistar; Skin Neoplasms | 2012 |
Stabilization of multiple metastatic epithelioid sarcoma under treatment with sunitinib malate.
Topics: Adult; Amputation Stumps; Amputation, Surgical; Antineoplastic Agents; Axilla; Drug Administration Schedule; Forearm; Hand; Humans; Indoles; Male; Muscle Neoplasms; Neoplasm Recurrence, Local; Pyrroles; Sarcoma; Skin Neoplasms; Sunitinib; Treatment Outcome; Umbilicus | 2013 |
Class II-specific histone deacetylase inhibitors MC1568 and MC1575 suppress IL-8 expression in human melanoma cells.
Topics: Acetylation; Cell Line, Tumor; Cell Proliferation; DNA-Directed RNA Polymerases; Drug Screening Assays, Antitumor; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Humans; Hydroxamic Acids; Interleukin-8; Melanoma; Promoter Regions, Genetic; Protein Binding; Proto-Oncogene Proteins c-jun; Pyrroles; RNA, Messenger; Skin Neoplasms; Tetradecanoylphorbol Acetate; Transcription Factor AP-1; Transcription Factor TFIIB; Transcription, Genetic; Uveal Neoplasms | 2013 |
Refractory cutaneous angiosarcoma successfully treated with sunitinib.
Topics: Administration, Oral; Aged; Antineoplastic Agents; Female; Hemangiosarcoma; Humans; Indoles; Pyrroles; Skin Neoplasms; Sunitinib; Treatment Outcome | 2013 |
Isoprenylation is necessary for the full invasive potential of RhoA overexpression in human melanoma cells.
Topics: Animals; Anticholesteremic Agents; Atorvastatin; Biocompatible Materials; Cell Movement; Collagen; Drug Combinations; Gene Expression Regulation, Neoplastic; Heptanoic Acids; Humans; Laminin; Melanoma; Neoplasm Invasiveness; Neoplasm Metastasis; Protein Prenylation; Protein Processing, Post-Translational; Proteoglycans; Pyrroles; rhoA GTP-Binding Protein; Signal Transduction; Skin Neoplasms; Transcription, Genetic; Tumor Cells, Cultured | 2002 |
c-Myc interacts with hypoxia to induce angiogenesis in vivo by a vascular endothelial growth factor-dependent mechanism.
Topics: Animals; Cell Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Indoles; Keratinocytes; Mice; Neovascularization, Physiologic; Oxindoles; Papilloma; Precancerous Conditions; Propionates; Proto-Oncogene Proteins c-myc; Pyrroles; RNA, Messenger; Skin; Skin Neoplasms; Tamoxifen; Transcription Factors; Transgenes; Vascular Endothelial Growth Factor A | 2004 |
UV-B phototoxic effects induced by atorvastatin.
Topics: Anticholesteremic Agents; Atorvastatin; Dermatitis, Phototoxic; Diagnosis, Differential; Female; Heptanoic Acids; Humans; Middle Aged; Pyrroles; Sezary Syndrome; Skin Neoplasms; Skin Tests; Ultraviolet Rays | 2006 |
Fatal hepatorenal failure and thrombocytopenia with SU5416, a vascular endothelial growth factor Flk-1 receptor inhibitor, in AIDS-Kaposi's sarcoma.
Topics: Acquired Immunodeficiency Syndrome; Angiogenesis Inhibitors; Fatal Outcome; Humans; Indoles; Liver Failure; Male; Middle Aged; Pyrroles; Renal Insufficiency; Sarcoma, Kaposi; Skin Neoplasms | 2007 |
Is 2,3,5-pyrroletricarboxylic acid in hair a better risk indicator for melanoma than traditional epidemiologic measures for skin phenotype?
Topics: Adult; Aged; Bayes Theorem; Case-Control Studies; Hair; Humans; Male; Melanins; Melanoma; Middle Aged; Phenotype; Pyrroles; Risk Factors; Skin Neoplasms; Spectroscopy, Near-Infrared | 2007 |
[Imatinib . Sunitinib].
Topics: Angiogenesis Inhibitors; Benzamides; Carcinoma, Renal Cell; Dermatofibrosarcoma; Drug Resistance, Neoplasm; Fusion Proteins, bcr-abl; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Indoles; Kidney Neoplasms; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Skin Neoplasms; Sunitinib; Survival Rate | 2007 |
Bexarotene combination therapy for patients with Sézary syndrome.
Topics: Antineoplastic Agents; Atorvastatin; Bexarotene; Drug Therapy, Combination; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pyrroles; Sezary Syndrome; Skin Neoplasms; Tetrahydronaphthalenes; Thyroxine | 2008 |
Measuring VEGF-Flk-1 activity and consequences of VEGF-Flk-1 targeting in vivo using intravital microscopy: clinical applications.
Topics: Analysis of Variance; Angiogenesis Inhibitors; Animals; Disease Models, Animal; Endothelial Growth Factors; Enzyme Inhibitors; Glioblastoma; Indoles; Lymphokines; Male; Mice; Mice, Nude; Microcirculation; Microscopy, Fluorescence; Microscopy, Video; Neoplasm Transplantation; Neovascularization, Pathologic; Protein Isoforms; Protein-Tyrosine Kinases; Pyrroles; Rats; Receptor Protein-Tyrosine Kinases; Receptors, Growth Factor; Receptors, Mitogen; Receptors, Vascular Endothelial Growth Factor; Signal Transduction; Skin Neoplasms; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2000 |
Potential carcinogenic and inhibitory activity of compounds isolated from Lilium candidum L.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Carcinogens; Ethanol; Liliaceae; Mice; Mutagens; Plant Extracts; Polarography; Pyrroles; Saponins; Skin Neoplasms; Tetradecanoylphorbol Acetate | 2000 |
Effects of some pyrrolic and dihydropyrrolizine esters on mouse skin: a preliminary study.
Topics: Alkylating Agents; Animals; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Pyrroles; Pyrrolizidine Alkaloids; Skin Neoplasms; Structure-Activity Relationship | 1979 |